Rubius Therapeutics, Inc.

NORTHERN TRUST CORP

Report date

12/31/2022

Quarter

2022 Q4

Filed

2/13/2023

Shares

71,366

Value ($000)

12

Weight

0.0%

2019 Q4 - 2022 Q4 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q4	2/13/2023	12	0.0%	71,366	12/31/2022
2022 Q3	11/14/2022	31	0.0%	71,493	9/30/2022
2022 Q2	8/12/2022	61	0.0%	71,493	6/30/2022
2022 Q1	5/13/2022	2,273	0.0%	412,525	3/31/2022
2021 Q4	2/8/2022	4,217	0.0%	435,677	12/31/2021
2021 Q3	11/15/2021	8,019	0.0%	448,459	9/30/2021
2021 Q2	8/13/2021	11,592	0.0%	474,841	6/30/2021
2021 Q1	5/12/2021	10,532	0.0%	397,413	3/31/2021
2020 Q4	2/11/2021	3,113	0.0%	410,024	12/31/2020
2020 Q3	11/16/2020	2,109	0.0%	420,872	9/30/2020
2020 Q2	8/14/2020	2,622	0.0%	438,447	6/30/2020
2020 Q1	5/14/2020	2,017	0.0%	453,313	3/31/2020
2019 Q4	2/14/2020	4,243	0.0%	446,648	12/31/2019